Congress Can Simplify the Healthcare Paperwork Burden


By Janet Trautwein

Almost nothing has sparked so much partisan debate in Washington as the Affordable Care Act. The two parties have been going back and forth over the healthcare law for more than a decade.

So it's encouraging to see lawmakers come together to support necessary administrative reforms to the ACA. Senators Mark Warner, D-Va., and Rob Portman, R-Ohio, and Representatives Mike Thompson, D-Calif., and Adrian Smith, R-Neb., have introduced the Commonsense Reporting Act of 2022 to streamline many of the ACA's regulatory compliance requirements.

Their bill would save taxpayers, employers, and consumers time, money, and countless headaches.

To see why, let's first take a look at the status quo. One of the key pillars of the Affordable Care Act is the "employer mandate," which requires employers with 50 or more full-time employees to offer health insurance to at least 95% of those workers. Any company that fails to comply faces fines.

Complying with the mandate isn't easy. Corporate health plans must conform to a raft of federal regulations. Crucially, those plans cannot cost workers more than 9.61% of their household income in 2022.

If an employee's share of her health plan premium exceeds that percentage, the employer may face a fine. The employee, meanwhile, may become eligible for subsidized coverage through the ACA's exchanges.

Lawmakers were trying to ensure that workers could afford the health plans their employers offered. But the income-based cutoff has created untold hassle for employers and employees alike.

Right now, employers report their health plan information to the Internal Revenue Service retroactively, in the following tax year. In other words, companies won't file their compliance paperwork regarding their 2022 health plans until spring 2023.

This creates problems for employers and employees alike.

Say an employee with an offer of coverage through work decides to take a look at the health plans available through their state exchange or HealthCare.gov. Those online marketplaces ask shoppers whether they've received an offer of "affordable" coverage through work.

They may not think that the employer-sponsored coverage that's available to them is "affordable." But the government has a specific definition of "affordable."

If they say that they were not offered affordable coverage -- whether because they thought their employer's plan was too expensive, or they preferred what was available on the exchanges -- they could be subject to thousands of dollars in penalties.

Meanwhile, the employer may have to incur additional costs and stress responding to questions from the IRS about whether it has actually offered "affordable" coverage.

Today's after-the-fact reporting system costs businesses and individuals billions of dollars each year. It's so complicated that it has an 82% error rate.

The Commonsense Reporting Act would fix these problems by shifting to a prospective filing system. As the Congressional Research Service summarizes, the reform would allow "employers to voluntarily report information about their health plans for the current plan year prior to the beginning of open enrollment."

That would enable employers and employees to have a better understanding of which workers qualify for ACA subsidies, which ones don't, and which ones must be covered by employer-sponsored plans.

The bill would also reduce government waste by eliminating the additional paperwork, hours of labor, and redundancies. That means there's effectively no cost to taxpayers.

The Commonsense Reporting Act is the rare bill that is a win-win-win for everyone involved: government, workers, and employers.

Janet Trautwein is CEO of the National Association of Health Underwriters (www.nahu.org). This piece originally ran in the Virginian-Pilot and Daily Press.



More Resources


05/07/2024
New Data Should Have Team Biden Sweating
A recent analysis published by the left-leaning Brookings Institution -- which highlights Pew data -- demonstrates significant erosion within Joe Biden's 2020 victory coalition, across multiple key demographics.

more info


05/07/2024
Who Will Be Dumb Enough To Become Trump's VP?
Who will be Donald Trump's vice presidential candidate? It's frankly remarkable that anyone would want the job.

more info


05/07/2024
Democrats Use Legal System To Target the Right
Laws that hamper Democrats are ignored.A Laws that might be used to hurt Republicans are enforced to a€” and often well past - the limits of the law.

more info


05/07/2024
Judge Merchan Is Out of Good Options
In April, when Judge Juan Merchan first heard arguments about whether Donald Trump was violating a gag order in his criminal case in Manhattan, he sharply and skeptically questioned the former president's attorneys, accusing one of "losing all credibility."

more info


05/07/2024
U.S. Research $ Should Support U.S. Values, Not Antisemitism
College campuses across America - and in particular across the Ivy League - have erupted with antisemitic, pro-Hamas encampments and riots. These anti-American activities are not the peaceful protests on college campuses of the past. They are federally funded demonstrations of support for terrorism. and the Biden administration is encouraging them.

more info


05/07/2024
Gaza War Protests Don't Yet Rival Anti-Vietnam War Movement
For many a baby-boomer, the sights and sounds of student protests against U.S. complicity in Israel's war in Gaza brought back vivid memories of the anti-Vietnam War movement of their youth and of the conservative backlash that ultimately placed its legacy in question.

more info


05/07/2024
Political Violence in America
The leftist tumult, often sliding into intimidation and violence, overtaking American college campuses is neither temporary nor topical. That is, it won't end when the war in Gaza ends, nor is it even particularly about that war. What we are seeing in 2024 is the latest, dreary iteration of left-wing violence that seems predictably to strike during election years.

more info


05/07/2024
Will Renewed U.S. Support for Ukraine Be Enough?
Ian Bremmer explains how an additional $61 billion in aid and arms will, and will not, change the course of the war.

more info


05/07/2024
Putin Won't March on Europe If We Stop Funding Ukraine
If Washington elites are hell bent on continuing to fund another war, impoverishing Americans as inflation is raging, they should pick a more clever excuse.

more info


05/07/2024
The Collapse of the News Is Taking Its Soul Down With It
A general view of the Kansas City bureau of the Associated Press. In the foreground is the East desk. Next is the Coast desk, then the State desks and in the background the Local desk, on April 22, 1940. | AP Corporate Archives

more info


05/07/2024
Lawmakers Urge U.S. Action To Halt China's Organ Trade
A group of leading China critics in Congress is urging the State Department to step up its efforts to curb Beijing's gruesome $1 billion forced organ harvesting trade, which targets ethnic and religious minorities, including Uyghurs, Tibetans, Muslims, Christians, and Falun Gong practitioners.

more info


05/07/2024
Inside the Cold Calculation of the Biden Brain Trust
In Wilmington, Joe Biden's reelection team is tackling stubborn polls, Gaza protests, and third-party threats as it assembles a sophisticated machine to defeat Donald Trump. And the stakes couldn't be higher: We could lose the thing that matters most to me, says campaign chair Jen O'Malley Dillon, which is a future for my kids.

more info


05/07/2024
The People Setting America on Fire
An investigation into the witches' brew of billionaires, Islamists, and leftists behind the campus protests

more info


05/07/2024
U.S. Forgets Disruption & Disorder Are Point of Protests
I have trespassed in peaceful protest. I have shutdown government offices in civil disobedience. I have made the powerful uncomfortable. That's the point

more info


05/07/2024
Biden Risks Radicalizing the Center
The president can reverse the chaos narrative. He must act.

more info



Custom Search

More Politics Articles:

Related Articles

5 Financial Pressure Points To Evaluate During COVID Times


Financial pressure is a part of life for most people, and now the COVID-19 pandemic has brought new financial pressure points or exacerbated existing ones for many individuals and families.

Why Are People Complaining About Innovative COVID Treatments?


Gilead Sciences just announced it will charge $3,120 for a full course of Remdesivir, the first new FDA-approved treatment for COVID-19. Some knee-jerk members of Congress like Lloyd Doggett (D-Tex.) immediately condemned that price tag as "outrageous." The Institute for Clinical and Economic Review, a left-leaning nonprofit that releases its own recommendations of "fair" drug prices, claimed that Gilead could afford to price Remdesivir as low as $10 per course of treatment -- the cost of the raw ingredients used to make the drug.

Proposed Healthcare Reforms Will Not Help the Latinx Community


Joe Biden is officially the Democratic presidential nominee, all thanks to his moderate reputation.

Trade Enforcement Can Accelerate America's Economic Recovery


The stock market has largely rebounded from COVID-19 and American retail sales are improving steadily. Even more encouraging is that the U.S. unemployment rate fell for the fifth consecutive month in September. Each of these gains are sure signs that the Trump administration's economic response to the coronavirus crisis is working.

Drug Price Controls: Right Objective, Wrong Solution


This month, President Trump signed an executive order to reduce Medicare spending on prescription drugs. For each medication, Medicare will pay no more than the lowest price available in other developed countries.

Keep Thanksgiving, Family and Friends Alive


Joe Biden or Donald Trump will never visit me in my home, stand beside me at the funeral home or dance at my wedding. I will not be receiving any calls from either of them to pray for me during sickness or to check on how my children are doing. I probably will never sit in a room with them to visit, laugh and tell funny stories or just to hang out over a cup of coffee. I do not personally know either one. I welcome the opportunity to visit with either of them, but doubt it will happen.

The "E" Stands for “Excellence:” Remembering Walter E. Williams


Walter E. Williams, prolific author, piercing cultural commentator, old school economist (that’s a good thing), devoted husband, loving father, and long-time friend of Grove City College has passed from this world.

How Congress Can Really Fix Surprise Billing


House and Senate leaders recently agreed on legislation to end surprise medical bills as part of a big coronavirus relief package. President Trump signed it into law at the end of December.

A Federal Rule Will Reverse Strides in Cancer Treatment


"You've got cancer." That's one of the scariest sentences in the English language.

Biden Must Restore Seniors' Access to Essential Medicines


On January 19, Medicare officials announced a new payment model that could wreak havoc on the chronically ill.

Violence In America, Don't Be Surprised


The most recent attack at the United States Capitol will most likely insure a permanent fence and additional security. The attack which resulted in the loss of life for a long serving Capitol police officer and the attacker is another senseless violent act.

Protecting the Innovation that Protects Global Health


The most far-reaching healthcare policy decision of 2021 won't be made in Congress or the White House. It will be made at the World Trade Organization, which is considering a petition to waive all patent rights on Covid-19 vaccines.

Don't Repeat Europe's Vaccine Catastrophe


For many Americans, the calamitously slow vaccine roll-out in countries like Germany, France, and Italy comes as a surprise. After all, in the early days of the pandemic, Europe's response to the crisis seemed highly competent, especially compared to the United States.

A Full Plate for the New U.S. Trade Czar


The newly confirmed U.S. trade representative, Katherine Tai, is about as qualified as a person can be for the job. Which is a good thing, because she already faces a series of challenges.

Don't Let the US Import Europe's Failed Cancer Policies


With a majority in both the House and Senate and control of the Oval Office, Democratic leaders are excited about the prospect of making significant changes. One good example of this is the House Democrats' "Lower Drug Costs Now Act."